This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Next Generation CAR & T Cell Therapies

LAST CHANCE: REGISTER BY MAY 20 TO SAVE UP TO $300

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
June 14-16, 2022
Delivered as a Hybrid EventIntercontinental Mark Hopkins Hotel, San Francisco, California

Yihong Yao
Lead Immuno Oncology Clinical Development, Translational Medicine and Oncology R&D at Cellular Biomedicine Group, USA & China

Agenda Sessions

  • Promising Safety and Efficacy Profile of a Novel Anti-CD20/CD19 Bi-Specific CAR-T (C-CAR039) Cell Therapy in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

    2:45pm